84 related articles for article (PubMed ID: 29960902)
1. In vivo identification of novel TGIF2LX target genes in colorectal adenocarcinoma using the cDNA-AFLP method.
Mobini GR; Ghafari A; Amanpour S; Fateh R; Ghahremani MH; Muhammadnejad S; Dehpour AR; Akbari A; Hoseiniharouni SM; Kazemirad E; Bolhassani M; Heidari M
Arab J Gastroenterol; 2018 Jun; 19(2):65-70. PubMed ID: 29960902
[TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor Beta-Induced Factor 2-Linked X (TGIF2LX) Regulates Two Morphogenesis Genes, Nir1 and Nir2 in Human Colorectal.
Mobini GR; Ghahremani MH; Amanpour S; Dehpour AR; Akbari A; Hoseiniharouni SM; Muhammadnejad S; Sheikhzade M; Abedkhojasteh H; Mohebi M; Bolhassani M; Heidari M
Acta Med Iran; 2016 May; 54(5):302-7. PubMed ID: 27309477
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
[TBL] [Abstract][Full Text] [Related]
4. Homeodomain Protein Transforming Growth Factor Beta-Induced Factor 2 Like, X-Linked Function in Colon Adenocarcinoma Cells.
Akbari A; Agah S; Heidari M; Mobini GR; Faghihloo E; Sarveazad A; Mirzaei A
Asian Pac J Cancer Prev; 2017 Aug; 18(18):2101-2108. PubMed ID: 28843229
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
[TBL] [Abstract][Full Text] [Related]
6. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
[TBL] [Abstract][Full Text] [Related]
7. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
8. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
[TBL] [Abstract][Full Text] [Related]
9. HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer.
Elnatan J; Murphy D; Goh HS; Smith DR
Br J Cancer; 1999 Nov; 81(5):874-80. PubMed ID: 10555761
[TBL] [Abstract][Full Text] [Related]
10. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
[TBL] [Abstract][Full Text] [Related]
11. Identification of differently expressed genes in human colorectal adenocarcinoma.
Chen Y; Zhang YZ; Zhou ZG; Wang G; Yi ZN
World J Gastroenterol; 2006 Feb; 12(7):1025-32. PubMed ID: 16534841
[TBL] [Abstract][Full Text] [Related]
12. FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
Mimori K; Ishii H; Nagahara H; Sudo T; Yamashita K; Inoue H; Barnard GF; Mori M
Cancer Res; 2006 Mar; 66(5):2683-90. PubMed ID: 16510588
[TBL] [Abstract][Full Text] [Related]
13. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
Zhang LQ; Wang H; Lai BT; Yue WT; Zhan XP; Yang XH; Zhang CY; Zhang TM
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):333-6. PubMed ID: 15949315
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
15. Aberrant FHIT transcripts in human colorectal cancers.
Lee SH; Lee SH
Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
[TBL] [Abstract][Full Text] [Related]
16. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
18. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
Liu F; Wu JZ; Li F; Li Y; Li J
Cytotherapy; 2008; 10(7):753-8. PubMed ID: 18985481
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]